Jeesa George. Pharmacovigilance During Pre-Approval Phases -Comparison of ICH E2E, CIOMS VI, FDA, EMEA/CHMP and CDSCO Risk Management Guidelines. IJPRSE [Internet]. 2022 Jul. 27 [cited 2024 Nov. 22];3(07):80-6. Available from: https://journal.ijprse.com/index.php/ijprse/article/view/667